The leading food & beverage leader TCP Group, announced a series of investments totaling more than USD 150 million over the next three years in China. The fresh investment by the company will expand Red Bull operations in China.
TCP has been establishing new partnerships and a new business model to ensure the long-term development of Red Bull in China.
At its heart, this ambitious strategy is focused on continuing to provide high-quality and legitimate Red Bull products to the vast number of Chinese consumers.
The new business model is in line with the business model that TCP follows around the world, which has allowed TCP to build such a strong international business through a network of trusted partners.
The investments will further expand TCP’s presence in the Chinese market by supporting its local partnerships, establishing a new representative office, in-country team, and manufacturing centers as well as supporting the launch of new Red Bull products and other innovative products from TCP’s global portfolio.
As part of the investments, TCP has carried out a series of feasibility studies aimed at exploring the possibility of opening new manufacturing centers in China.
TCP is committed to investing further in the Huairou District by opening a new manufacturing center.
The local government has been providing support and assistance to facilitate this undertaking despite the many challenges presented by the COVID-19 pandemic.
About TCP Group
T.C. Pharma is a Thailand based leading food and beverage company. TCP is a leading inventors and owners of the Red Bull brand and trademarks in China and globally. The company has a diverse product portfolio comprising four product categories energy drinks, electrolyte beverages, functional drinks and snacks and more than 30 product lines under nine brands. The company is the only producer of the Red Bull flavor around the world ensuring only quality ingredients are used in Red Bull worldwide.